Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Times Interest Earned (2020 - 2026)

Cytek Biosciences filings provide 6 years of Times Interest Earned readings, the most recent being $7.72 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 1633.09% to $7.72 in Q4 2025 year-over-year; TTM through Dec 2025 was -$85.2, a 2274.95% decrease, with the full-year FY2025 number at -$85.2, down 2274.9% from a year prior.
  • Times Interest Earned hit $7.72 in Q4 2025 for Cytek Biosciences, up from -$18.61 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $8.8 in Q2 2021 to a low of -$63.63 in Q2 2024.
  • Median Times Interest Earned over the past 5 years was -$2.69 (2022), compared with a mean of -$12.29.
  • Biggest five-year swings in Times Interest Earned: crashed 1520.43% in 2023 and later soared 1633.09% in 2025.
  • Cytek Biosciences' Times Interest Earned stood at $2.68 in 2021, then crashed by 95.43% to $0.12 in 2022, then plummeted by 384.38% to -$0.35 in 2023, then crashed by 44.74% to -$0.5 in 2024, then soared by 1633.09% to $7.72 in 2025.
  • The last three reported values for Times Interest Earned were $7.72 (Q4 2025), -$18.61 (Q3 2025), and -$25.66 (Q2 2025) per Business Quant data.